Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial	Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy	Recruiting	Phase 2	2025-05-28		NCT06992128

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Nantong University	71
Afﬁliated Hospital of North Sichuan Medical College	16
Baoding First Central Hospital	6
Changzhi Medical College	6
Institute of Hematology & Blood Diseases Hospital, China	285
North China University of Science and Technology	7
Shenzhen Second People's Hospital	31
The Affiliated Hospital of Qingdao University	124
The First Affiliated Hospital of Bengbu Medical University	47
The Second Affiliated Hospital of Dalian Medical University	18
Tianjin Hospital of ITCWM-Nankai Hospital	1
Weifang People's Hospital	30

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chinese Academy of Medical Science and Blood Disease Hospital	Tianjin	China	15